Sign in

CIK 0001590750

  • Large accelerated filer

Viridian Therapeutics, Inc.DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471187261
Phone
+1 617-272-4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-03 Beetham Thomas W. Chief Operating Officer Shares withheld for taxes −3,048 $30.19 $92K 13,361
2026-03-03 Beetham Thomas W. Chief Operating Officer Exercise or conversion +9,409 16,409
2026-03-03 Beetham Thomas W. Chief Operating Officer Shares withheld for taxes −3,138 $29.32 $92K 13,271
2026-03-03 Beetham Thomas W. Chief Operating Officer Exercise or conversion · Restricted Stock Units −9,409 28,227
2026-03-02 Beetham Thomas W. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +176,550 176,550
2026-03-02 Beetham Thomas W. Chief Operating Officer Grant or award · Restricted Stock Units +35,300 35,300
2025-03-03 Beetham Thomas W. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +225,814 225,814
2025-03-03 Beetham Thomas W. Chief Operating Officer Grant or award · Restricted Stock Units +37,636 37,636
2024-09-27 Beetham Thomas W. Chief Operating Officer Purchase +5,000 $23.41 $117K 6,000
2023-10-30 Beetham Thomas W. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +474,400 474,400

Page 1 of 1 · 10 trades